Consulting Businesses for Sale and Investment in Brussels

A deep-tech company based in Flanders, Belgium, was established in February, 2 years ago. We specialize in delivering Artificial Intelligence (AI) and advanced Modeling & Simulation (M&S) solutions to the pharmaceutical industry, operating at the intersection of computational science and drug development. - Our core offerings include a proprietary Software-as-a-Service (SaaS) platform and specialized consulting services spanning the entire drug development lifecycle—from early discovery to late-stage development—including market access, pricing, and value demonstration for novel therapies. - We serve a diverse global client base across the pharmaceutical, biotechnology, and medical device sectors. - Our clientele includes key players such as Deloitte Belgium, UCB Pharma, Fresenius Kabi, B. Braun, and Translucency Ltd. - Through data-driven insights, we enable these partners to accelerate product development and optimize their market strategies. - The company has demonstrated consistent operational growth since its inception. Our revenues reflect this trajectory, with €76,000 reported two years ago, €118,062 last year, and a projected €164,200 for this fiscal year (ending in June). - The company maintains a stable financial position, underpinned by a net working capital of approximately €50,000, and has been awarded a €50,000 grant by VLAIO (Flanders Agency for Innovation and Entrepreneurship) to further develop our platform.

A deep-tech company based in Flanders, Belgium, was established in February, 2 years ago. We specialize in delivering Artificial Intelligence (AI) and advanced Modeling & Simulation (M&S) solutions to the pharmaceutical industry, operating at the intersection of computational science and drug development. - Our core offerings include a proprietary Software-as-a-Service (SaaS) platform and specialized consulting services spanning the entire drug development lifecycle—from early discovery to late-stage development—including market access, pricing, and value demonstration for novel therapies. - We serve a diverse global client base across the pharmaceutical, biotechnology, and medical device sectors. - Our clientele includes key players such as Deloitte Belgium, UCB Pharma, Fresenius Kabi, B. Braun, and Translucency Ltd. - Through data-driven insights, we enable these partners to accelerate product development and optimize their market strategies. - The company has demonstrated consistent operational growth since its inception. Our revenues reflect this trajectory, with €76,000 reported two years ago, €118,062 last year, and a projected €164,200 for this fiscal year (ending in June). - The company maintains a stable financial position, underpinned by a net working capital of approximately €50,000, and has been awarded a €50,000 grant by VLAIO (Flanders Agency for Innovation and Entrepreneurship) to further develop our platform.